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It has been shown that in hereditary and most sporadic colon tumours, components of the Wnt pathway are mutated. The Wnt
target MET has been implicated in the development of colon cancer. Here, we show that overexpression of wild-type or a
constitutively activated form of MET in colon epithelial cells leads to increased transformation irrespective of Wnt signalling. Fetal
human colon epithelial cells without aberrant Wnt signalling were transfected with wild-type or mutated MET constructs. Expression
of these constructs leads to increased phosphorylation of MET and its downstream targets PKB and MAPK. Upon stimulation with
HGF, the expression of E-cadherin is downregulated in wild-type MET-transfected cells, whereas cells expressing mutated MET show
low E-cadherin levels independent of stimulation with ligand. This implies a higher migratory propensity of these cells. Furthermore,
fetal human colon epithelial cells expressing the mutated form of MET have colony-forming capacity in soft agar, while cells expressing
wild-type MET show an intermediate phenotype. Subcutaneous injection of mutated MET-transfected cells in nude mice leads to the
formation of tumours within 12 days in all mice injected. At this time point, mock-transfected cells do not form tumours, while wild-
type MET-transfected cells form subcutaneous tumours in one out of five mice. We thus show that MET signalling can lead to
increased transformation of colon epithelial cells independent of Wnt signalling and in this way could play an essential role in the
onset and progression of colorectal cancer.
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Colorectal cancer (CRC) is common in the Western world and
accounts for a high amount of cancer-related deaths. Advances in
molecular genetics have greatly increased our understanding of the
development of CRC (Liu et al, 1992; Kinzler and Vogelstein, 1996;
Korinek et al, 1997). Colorectal cancer evolves through a series of
morphologically recognisable stages known as the adenoma–
carcinoma sequence (Vogelstein et al, 1988). Mutations involving
components of the Wnt signalling pathway are essential for the
initial neoplastic transformation. These mutations lead to accu-
mulation of b-catenin in the nucleus, where it activates TCF-
mediated transcription (Bienz and Clevers, 2000). Transcription of
TCF-regulated genes, including cyclinD1 (Shtutman et al, 1999), c-
Myc (He et al, 1998) and CD44 (Wielenga et al, 1999), is thought to
impose a stem cell phenotype on colon cells and provides a basis
for their proliferative capacity. Recently, we identified the receptor
tyrosine kinase MET as a target of Wnt signalling, suggesting a role
for MET in controlling the turnover and differentiation of
intestinal epithelium (Boon et al, 2002).
Apart from being crucial in mammalian development and
epithelial morphogenesis, MET is overexpressed in several human
cancers and germline mutations of the MET gene have been
reported in hereditary papillary renal carcinoma (Schmidt et al,
1997). These mutations induce enhanced enzymatic activity of the
MET tyrosine kinase, which may lead to increased transforming
and tumorigenic properties (Jeffers et al, 1997). Activation of MET
by either ligand stimulation or overexpression of the receptor is
thought to depend upon receptor dimerisation or oligomerisation,
resulting in transphosphorylation. In addition, different mutations
in the tyrosine kinase domain have been found, including L1213V
and M1268T, which lead to constitutive activation of the receptor
(Jeffers et al, 1997; Schmidt et al, 1997; Jeffers et al, 1998).
In CRC, MET is overexpressed in the vast majority of adenomas,
invasive carcinomas, and metastases (Di Renzo et al, 1991, 1995;
Liu et al, 1992; Wielenga et al, 2000). In addition, MET has been
shown to be amplified in primary colorectal tumours as well as in
liver metastasis (Di Renzo et al, 1995). We previously showed that
MET overexpression in the initial phase of CRC is ‘regulatory’ and
results from enhanced Wnt signalling (Boon et al, 2002). We
furthermore hypothesise that in addition to Wnt signaling, other
pathways could regulate MET expression and that overexpression
of MET could also have an effect on tumorigenesis irrespective of
Wnt signalling.
In the present study, we show that overexpression of wild-type
MET or a constitutively active form of MET in primary fetal human
colon epithelial cells leads to an initial growth advantage, irrespective
of aberrant Wnt signalling, resulting in increased tumorigenicity.
MATERIALS AND METHODS
Plasmid constructions
All constructs described were subcloned into pcDNA3.1. To
generate the expression vector, a 4.2kb BamHI–BamHI fragment Revised 19 November 2004; accepted 16 December 2004
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sof mouse Met (kindly provided by George Vande Woude) was
subcloned into the BamHI sites of pcDNA3.1 vector. The resulting
plasmid was designated wild-type Met (WTMet). Site-directed
mutagenesis was used to generate the mutations L1213V and
M1268T in Met, and mutations were verified by sequencing both
strands of DNA. This plasmid was designated Met mutated
(Metmut). As a control, the empty vector was used.
Cell culture and transfections
Primary fetal human colon epithelial cells (FHC) (CRL-1831,
ATCC, Manassas, VA, USA) were cultured in a 1:1 mixture of
DMEM and Ham’s nutrient mixture, supplemented with 10% fetal
calf serum (FCS), 25mM HEPES, 10ngml
 1 cholera toxin,
5mgml
 1 insulin, 5mgml
 1 transferrin and 100ngml
 1 hydro-
cortisone. DLD1 (kindly provided by H Clevers) and HCA-7 cells
(parental cell line kindly provided by J Tuynman) were grown in
RPMI medium and DMEM medium, respectively, supplemented
with 10% FCS, 100Uml
 1 penicillin and 100mgml
 1 streptomycin
(all from Life Technologies, Paisley, UK). Cells were transiently
transfected with either 5mg empty vector, WTMet or Metmut
plasmids using lipofectamine (Invitrogen, Paisley, UK). To correct
for differences in transfection efficiency, cells were cotransfected
with a reporter plasmid containing a GFP gene (Clontech.,
Palo Alto, CA, USA). The ratio of Met-containing plasmid to
GFP-encoding plasmid was 5:1. Transfection efficiency was
determined in live cells by counting, with a fluorescence
microscope fitted with phase contrast optics, the number of
GFP-positive cells as well as the total cell number in 10
independent optical fields. The resulting transfection efficiency
was used to correct for differences in transfection in each culture
well in each experiment.
TCF reporter assay
Cells were transiently transfected with either pTOPflash or
pFOPflash reporter plasmids (Upstate Biotechnology, Lake Placid,
NY, USA) and different Met-encoding plasmids using lipofecta-
mine (Invitrogen, Paisley, UK). To correct for differences in
transfection efficiency, cells were cotransfected with a Renilla
luciferase encoding plasmid. All experiments were performed in
triplicate. At 48h after transfection, cells were lysed in luciferase
reporter lysis buffer and monitored for luciferase and renilla
activity using a Dual-Luciferase Reporter Assay System (Promega,
Madison, NY USA). Light units were recorded using a lumin-
ometer.
Western Blot analysis
Cells were transiently transfected using lipofectamine. At 30h after
transfection, cells were starved overnight in medium containing
0.1% serum, after which cells were stimulated with 100ngml
 1
HGF for 3min (Relia Tech. Inc., Breda, The Netherlands). At 48h
after transfection, protein extracts were prepared in lysis buffer
(10mM Tris pH 8.0; 15mM NaCl; 1% NP40, 10% glycerol;
0.4mgml
 1 sodium orthovanadate). Proteins were separated by
SDS–PAGE and blotted onto immobilon-P transfer membranes
(Millipore Corp., Bedford, MA, USA) by tank blotting. Membranes
were blocked in Tris-buffered saline (100mM Tris-Cl pH 7.5;
150mM NaCl) containing 0.1% Tween (Sigma, St Louis, MO, USA)
and 5% nonfat dry milk, probed with monoclonal antibodies – AC-
15 (against b-Actin) (Sigma), HECD-1 (against E-cadherin)
(Takara Bio Inc., Otsu, Shiga, Japan) – and polyclonal antibodies
– Rabbit anti-Met SP260 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), Rabbit anti-c-Met phosphospecific pYpYpY
1230/1234/1235
(Biosource, Camarillo, CA, USA), rabbit anti-Phospho-Akt (ser
473) (Cell Signalling Technology, Beverly, MA, USA), rabbit anti-
Akt (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-
MAPK (Erk 2) (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
or rabbit anti-Phospho-p44/42 MAPK(Thr 202/Tyr 204) (New
England Biolabs, Hitcin, UK). Proteins were detected with horse-
radish peroxidase-conjugated secondary antibodies (Dakopatts,
Glostrup, Denmark) in a standard chemiluminescence Western
Blotting protocol (ECL Western Blotting, Amersham Pharmacia
Biotech Inc., Aylesbury, UK).
Confocal microscopy
Fetal human colon epithelial cells were grown to 60% confluency
on glass coverslips in six-well plates. Cells were transiently
transfected with either 5mg empty vector, WTMet or Metmut
plasmids using lipofectamine. At 30h after transfection, cells were
starved overnight in medium containing 0.1% serum, after which
cells were grown for 24h with 100ngml
 1 HGF. Cells grown on
coverslips were fixed in cold methanol and processed for indirect
immunofluorescence. Slides were stained with a mouse mono-
clonal antibody HECD-1 (Takara Bio Inc., Otsu, Shiga, Japan)
against E-cadherin, and bound antibodies were detected using
RPE-conjugated goat anti-mouse antibodies (Jackson Laboratory,
Main, USA). Slides were analysed on a Leica TCS NT confocal
microscope (Leica, Inc., Heidelberg, Germany).
Soft agar assay
For analysis of colony formation in soft agar, cells were trypsinised
2 days after transfection, counted and 5000 cells were resuspended
in complete medium containing 0.5% seaplaque agar (Bioproducts,
Rockland, ME, USA). Cells were seeded in six-well plates
(2mlwell
 1) containing a 1% seaplaque agar underlay and
supplemented three times a week with complete medium. After
10 days of growth, colonies were stained with an aqueous solution
containing 0.5mgml
 1 NADH with 0.5mgml
 1 nitro blue
tetrazolium salt. Following overnight incubation at 371C, colonies
were counted using Image Pro software.
Tumorigenicity assay
Transfected cells (2.5 10
5) were injected subcutaneously in the
neck of 6-week-old male nude mice (BALB/cAnNCrl-nuBR,
Charles River) (n¼5 per experimental group). Mice were
examined every 2 days and tumour length and width were
measured using calipers. After 19 days, mice were euthanized and
tumours, livers and spleens were excised for histopathological
processing.
RESULTS
HCA-7 cells have high expression of MET protein levels
independent of active Wnt signalling
In a human hereditary nonpolyposis colorectal cancer (HNPCC)-
derived cell line (HCA-7), we observed a high level of MET
expression. This MET protein expression was comparable to an
established CRC cell line, DLD1, which contains mutations in the
APC gene (Figure 1A). HCA-7 cells have, however, no mutations in
APC or b-catenin (Ilyas et al, 1997; Rowan et al, 2000), resulting in
low TCF-mediated transcription as shown in Figure 1B. The TOP/
FOP ratio in DLD1 cells was 7.4 compared to TOP/FOP ratios
below 2 in HCA7 cells (Figure 1B). High expression levels of Met
without aberrant Wnt signalling in these cells indicates that
expression of MET next to regulation by the Wnt pathway could be
regulated by an additional signalling pathway. Furthermore, MET
could have an effect on tumorigenesis irrespective of Wnt
signalling.
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signalling
To explore our hypothesis that MET has transforming capacity
irrespective of Wnt signalling, we used primary FHC epithelial
cells. Using a TCF reporter assay, we found that these FHC
epithelial cells have no detectable TCF-mediated transcription. We
compared the TOPflash activity of the FHC cells to the TOPflash
activity of DLD1 cells. The TOPflash activity of the colon epithelial
cells transfected with empty vector or with different Met constructs
was very low as compared to the DLD1 cells (Figure 2). The TOP/
FOP ratio in DLD1 cells was 7.4 compared to TOP/FOP ratios
below 2 in FHC cells. Therefore, no active Wnt signalling could be
found in the FHC cells, irrespective of the overexpression of the
wild-type or mutant Met.
Expression of wild-type or mutated Met constructs in FHC
epithelial cells leads to increased phosphorylation of Met
and its downstream targets PKB and MAPK
Although the colon epithelial cells have no active Wnt signalling,
they have detectable Met protein levels. In addition, transient
expression of wild-type or mutated Met constructs resulted in
higher Met protein levels as compared to the mock-transfected
cells containing endogenous Met protein (Figure 3). The increase
in expression was relatively small due to a low transfection
efficiency (10–20%). However, probing of the filter with anti-
phospho Met antibody demonstrated that this level of over-
expression of mutationally activated Met could lead to enhanced
autophosphorylation levels of the receptor. This also gave rise to
activation of the effector molecules PKB and MAPK, as shown by
staining with anti-phospho PKB or anti-phospho MAPK anti-
bodies, respectively (Figure 3). This effect was marked, although
only 10–20% of the cells were transfected. As a control, total
protein levels of PKB, MAPK and Actin were measured. Activation
of Met and its downstream targets could still be increased by the
addition of HGF in mock-transfected cells as well as in the cells
transfected with WTMet constructs. However, mutations in the
kinase domain of MET lead to constitutively activated Met
signalling independent of ligand stimulation (Figure 3).
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Figure 1 HCA-7 cells have high expression of MET protein levels
independent of aberrant Wnt signalling. MET protein levels in HCA-7 cells
were compared to the MET levels in a CRC cell line DLD1 and in fetal
colon epithelial cells. As a loading control, b-Actin was used (A). This Met
expression was independent of active Wnt signalling as shown by the TOP/
FOP ratios present in these cells compared to DLD1 cells, containing active
Wnt signalling (B).
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Figure 2 There is no active Wnt signalling in the fetal colon epithelial
cells. TOPflash and FOPflash activities were measured in colon epithelial
cells containing empty vector, WTMet or Metmut constructs. As a positive
control for active Wnt signalling, TOPflash and FOPflash activities were also
measured in DLD1 cells. Measurements were corrected for differences in
transfection efficiency using a Renilla luciferase-encoded construct.
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Figure 3 Overexpression of WT or mutated MET leads to higher
phosphorylation levels of MET and its downstream targets PKB and MAPK.
Fetal human colon epithelial cells were transiently transfected with empty
vector, WTMet or Metmut constructs. Cells were stimulated with
100ngml
 1 HGF for 3min and protein lysates were prepared. Blots were
stained with the following antibodies: anti-MET, anti-phospho-Met, anti-
phospho-PKB, anti-phospho-MAPK and as loading control, anti-PKB, anti-
MAPK and anti-b-Actin.
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MET constructs
To translate these biochemical data to functional data, we looked
at the scatter capacity of transfected colon epithelial cells. Since the
transfection efficiency was limited in these cells (10–20%
efficiency), it was important to distinguish between transfected
and untransfected cells. In all transfection experiments, we
therefore cotransfected the cells with a plasmid encoding GFP (at
a ratio of 5:1 for the Met-containing plasmid:GFP-encoding
plasmid) to control for transfection efficiency and for identifica-
tion purposes. By observing the GFP-positive cells using confocal
microscopy, we could identify the transfected cells. Expression
levels of E-cadherin were thus investigated in these GFP-positive
cells only. E-cadherin is a component of adherens junction
complexes. Previous studies have shown that the level of E-
cadherin is negatively correlated with the migratory/scatter
capacity of colon carcinoma cells (Masur et al, 2001). Confocal
microscopy analysis of transfected cells on glass coverslips
revealed high levels of E-cadherin in mock-transfected cells and
slightly diminished levels of E-cadherin after 24h HGF stimulation
(Figure 4A, upper panel). Cells containing the wild-type Met
construct showed intermediate levels of E-cadherin, with reduced
levels after ligand stimulation (Figure 4A, middle panel). Low
levels of E-cadherin were observed in cells containing the mutated
form of Met independent of ligand stimulation (Figure 4A, lower
panel). In parallel, protein lysates of the transfected cells were
prepared and E-cadherin levels were studied by Western blot
analysis. Blots were analysed by densitometry and signals were
normalised for loading by comparison with the appropriate b-actin
signal. E-cadherin levels were downregulated up to 7% in WTMet-
overexpressing cells (Figure 4B). In cells transfected with a mutant
Met construct, E-cadherin levels were downregulated by 15% even
without ligand stimulation (Figure 4B). Thus, even on a back-
ground of 80–90% untransfected cells, the downregulation of E-
cadherin could still be visualised by Western blot analysis.
Expression of WT or mutated Met constructs leads to
colony formation of colon epithelial cells
To further explore our hypothesis that overexpression of MET,
irrespective of Wnt signalling, leads to transformation of primary
colon epithelial cells, we performed soft agar assays with the
transfected cells. Colony formation of cells in soft agar is used as a
method to identify the capacity to grow anchorage independent
and is a measurement for transformed cells. This assay thus gives
more information about growth, survival and transformation of
cells. Mock-transfected cells did not grow efficiently in soft agar,
while cells overexpressing wild-type or mutant Met proteins were
able to form colonies in soft agar within 10 days (Figure 5).
Expression of mutated Met resulted in high transforming capacity,
leading to the largest number and size of colonies compared to
mock- and wild-type Met-transfected cells (Figure 5). The increase
in the amount of colonies compared to mock-transfected cells was
six-fold for WTMet-transfected cells and mutant Met-transfected
cells formed eight times more colonies in soft agar (average values
from five independent experiments).
Tumour formation in nude mice
To investigate whether these in vitro data have an in vivo correlate,
we injected the transfected colon epithelial cells subcutaneously in
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Figure 4 E-cadherin expression is downregulated by stimulation with HGF in mock- and WTMet-transfected cells or by the expression of constitutively
active Met. Fetal human colon epithelial cells were cultured on glass coverslips and transfected with empty vector, WTMet or Metmut constructs and grown
with or without the addition of 100ngml
 1 HGF for 24h. Slides were processed for indirect immunofluorescence and analysed on a confocal microscope
for E-cadherin expression. Arrows depict cell–cell boundaries (A). In parallel, protein lysates were prepared and blots were stained for E-cadherin
expression. As a control, b-Actin was used. The calculated values by densitrometry are shown for E-cadherin protein levels (B).
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sthe neck of nude mice. Within 12 days after injection, cells
transfected with mutated Met formed tumours in all treated mice
(five out of five mice). At this time point, only one out of five mice
of the WTMet cell-injected group had a palpable tumour, but none
of the mice injected with cells containing empty vector had
tumours (Figure 6A). Tumour growth was followed for a total of 19
days. Cells containing a mutated form of the Met receptor had an
initial growth advantage over WTMet- or mock-transfected cells
(Figure 6A and B). No metastases were detected in the liver or the
spleen after 19 days. Thus, overexpression of wild-type or
constitutively active Met leads to transformation of colon epithelial
cells independent of active Wnt signalling in both in vitro as well
as in vivo models.
DISCUSSION
Transformation of normal intestinal epithelial cells to dysplastic
cells and eventually carcinoma cells comprises different stages
(Vogelstein et al, 1988). Within these stages, several genes are up/
downregulated or mutated, leading to tumour progression. It has
been shown that the earliest neoplastic lesions in CRC are caused
by mutations in components of the Wnt signalling pathway
including APC and b-catenin (Bienz and Clevers, 2000). Also, in
more than 85% of the sporadic tumours, the APC gene is mutated,
indicating the importance of active Wnt signalling and subsequent
transcription of TCF target genes in the onset of CRC. Our group
has shown that the receptor tyrosine kinase MET is overexpressed
during all stages of the adenoma–carcinoma sequence (Wielenga
et al, 2000; Boon et al, 2002). Furthermore, we identified MET as a
Wnt signalling target gene, indicating that the expression of Met in
the majority of both hereditary as well as sporadic colon tumours
is a consequence of active Wnt signalling (Boon et al, 2002).
However, in a HNPCC-derived cell line (HCA-7), where constitu-
tively active Wnt signalling is not present, we also observed high
levels of MET expression. In addition to regulation by the Wnt
pathway, expression of MET could therefore be regulated by other
signalling pathways. This should be investigated in more detail.
Nevertheless, it is evident that MET is overexpressed in colorectal
tumours with or without the presence of active Wnt signalling,
implying an important role for MET in the onset and progression
of CRC. We, therefore, further investigated the role of MET on
transformation of primary colon epithelial cells and explored the
possibility that MET signalling could lead to an initial growth
advantage independent of aberrant Wnt signalling, resulting in
increased tumorigenicity.
To investigate the transforming capacity of the receptor tyrosine
kinase MET in colon epithelium, we used FHC epithelial cells.
These cells exhibit characteristics typical of epithelial cells and are
capable of approximately 15 population doublings. Karyotyping of
these cells showed that these cells are aneuploid, thereby
explaining the ability of these cells to grow in vitro (data not
shown). However, these cells go into senescense after 15
population doublings, showing that these cells are not immorta-
lised. Furthermore, we investigated whether these cells have active
Wnt signalling, the hallmark for colorectal cancer cells. A TCF
reporter assay showed that there is no aberrant Wnt signalling
present. Also, transient transfection of the colon epithelial cells
with constructs containing wild-type or mutated Met did not lead
to active Wnt signalling. This finding is in contrast to previous
studies (Danilkovitch-Miagkova et al, 2001; Monga et al, 2002;
Herynk et al, 2003) showing that activation of Met leads to
activation of b-catenin. Although we have no formal prove for this
discrepancy, we believe that this could be due to the cell system
used.
Expression of WTMet or Metmut in the FHC cells lead to
overexpression and to increased phosphorylation of the receptor
and its effector molecules MAPK and PKB. Although the basal
levels of phospho-PKB are low in colon carcinoma cells, still an
activation of PKB was present after overexpression of wild-type
and mutated Met. Although wild-type MET does not normally
signal independent of HGF stimulation, overexpression of receptor
tyrosine kinases could lead to dimerisation and autophosphoryla-
tion and hence mimicks a continuous presence of ligand (reviewed
in Schlessinger, 2000). In addition to enhanced signalling of the
MET pathway, E-cadherin levels were downregulated after HGF
stimulation in mock- and WTMet-transfected cells and a mutated
Met construct diminished E-cadherin expression in the transfected
cells independent of ligand stimulation. This was shown by
confocal microscopy as well as by Western blot analysis. The
Mock WTMet
Six - fold Eight - fold
Metmut
Figure 5 Overexpression of WT or mutated MET leads to colony
formation in soft agar. Fetal human colon epithelial cells were transfected
with empty vector, WTMet or Metmut constructs, trypsinised and 5000
cells were used in a soft agar assay. Cells were grown in soft agar for 10
days, after which colonies were stained and counted. Increase in the
amount of colonies is determined in comparison to the amount of colonies
from the mock-transfected cells.
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Figure 6 Overexpression of WT or mutated MET leads to tumour
growth in nude mice. At 24h after transfection with WTMet or Metmut
constructs, FHC cells were injected into nude mice (five mice per group).
Mice were monitored for tumour growth. First tumours were visible 12
days after injection and were followed for a total of 19 days. The number of
mice with tumours (A) and tumour size (B) were measured in time.
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due to the under-representation of transfected cells in the total
pool. E-cadherin is a homotypic adhesion molecules involved in
cell–cell contact (Huttenlocher et al, 1998; Horwitz and Parsons,
1999; Masur et al, 2001). Cells with a high level of E-cadherin have
relatively low migratory capacity (Masur et al, 2001). Our results
showing that overexpression of MET causes downregulation of E-
cadherin expression therefore implies a higher migratory propen-
sity of these cells. Furthermore, low E-cadherin expression levels
are used as a diagnostic marker for malignant cells, indicating that
the transfected colon epithelial cells are transformed. In line with
these data, transfected cells containing mutant MET were able to
form colonies in soft agar. This shows that these cells have higher
survival and growth capacity due to increased transformation. In
vivo experiments further confirm our hypothesis that MET plays a
role in tumour formation, showing that cells overexpressing WT or
mutated MET can indeed form tumours within 12 days after
injection.
We show that overexpression of the receptor tyrosine kinase
MET in primary colon epithelial cells activates downstream
signalling molecules. Activation of this signalling pathway leads
to a diminished E-cadherin expression, colony-formation capacity
and subsequent tumour growth in nude mice. We propose that
upregulation of MET could lead to transformation of colon
epithelial cells and can initiate and enhance tumour growth in
colorectal cancer irrespective of Wnt signalling.
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